The Effect of a Self-Management Lymphedema Education Program on Lymphedema, Symptoms, Compliance, Daily Living Activities, and Patient Activation in Breast Cancer-Related Lymphedema: A Quasi-Experimental Study

Gizem Cansiz Ucar

Status: Completed

Conditions: Breast Cancer Survivor; Lymphedema

Treatments: Other: self-management lymphedema (SML) education program

Study type: Interventional

Funder types: Other

Identifiers

NCT06766708

KA-19098

Details and patient eligibility

About

The aim of this pre-test post-test quasi-experimental study is to evaluate the effects of a self-management lymphedema (SML) education program on patient adherence, daily life activities, and patient activation in individuals with breast cancer-related lymphedema (BCRL). This study involves 44 patients diagnosed with BCRL and is conducted at Hacettepe University Oncology Hospital Lymphedema Diagnosis and Treatment Application and Research Center. Upper extremity lymphedema assessments are performed at the beginning of the study, followed by the implementation of a structured SML education program. Participants are monitored for a total of 12 months. Data collection tools include the Personal Information Form, Upper Extremity Lymphedema Diagnosis Form, Adaptation to Chronic Illness Scale, KATZ Daily Living Activities Index, Disability of Arm, Shoulder, and Hand Questionnaire, and Patient Activation Measure.

Full description

This study focuses on evaluating the potential benefits of a structured self-management lymphedema education program in patients with breast cancer-related lymphedema. It aims to improve patient adherence, activation, and daily life activity levels through a comprehensive education-based intervention.The study was conducted as a master's thesis and has been completed.

Enrollment: 44 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Being female,
• Aged 18 years or older,
• Having undergone axillary lymph node dissection,
• Having undergone breast cancer surgery,
• Diagnosed with lymphedema (stage 1-2),
• Individuals with no surgical plans during the study period.

Exclusion criteria

• Not diagnosed with lymphedema,
• Having a medical condition that prevents exercise,
• Having advanced-stage heart or kidney failure,
• Patients who refused to participate in the study.

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

44 participants in 1 patient group

Experimental grup

Experimental group

Description:

one group quasi-experimental study was to determine the effects of self-management lymphedema (SML) education program on the patient adherence, daily life activities and patient activation in patients with breast- cancer related lymphedema (BCRL).

Treatment:

Other: self-management lymphedema (SML) education program